It is with great sadness that we have to inform you that on July 31st 2014 Lodewijk Bos passed away.
Call for candidates. Deadline extended until August 24th.
WHO resolution number 20; conference; forum; and request for input for the new edition of the regulations book.
On 04 July 2014, the General Secretariat of the Council of the European Union published a document addressed to the Working Party on Pharmaceuticals and Medical Devices in relation to the Council’s modifications to the Proposal for a Medical Devices Regulation. The document specifically deals with chapter VI on Clinical Evaluation and Clinical Investigations under the MDR and the in-vitro Medical Devices Regulation.
New UK report highlights the need for urgent action to prioritise the role of biomedical engineers in the NHS
The urgent need for biomedical engineers in the UK National Health Executive (NHS), the world’s largest healthcare system was highlighted by a new report entitled: Biomedical Engineering: Advancing UK healthcare. The report was published by the Institution of Mechanical Engineers UK on the 25 July 2014.
IMI 2 will hold an Open Info Day on its IMI 2-Call 1 in Brussels, Belgium on Tuesday 30 September 2014. In a similar vein to the Webinars held in July, the day will encompass an overview of IMI 2’s funding and intellectual property (IP) rules, funding advice so as to facilitate ease of applying under IMI 2, and workshops and presentations of the IMI 2-Call 1 Call topics by the project coordinator. Additionally, there will be plenty of networking opportunities and IMI staff will be on hand to answer questions relating to the new Call topics and the IMI 2 application procedures. It is important to note that additional information about the IMI 2-Call 1 will be communicated after approval by the IMI Governing Board (July/August 2014).
The Innovative Medicines Imitative 2 (IMI) has announced that it will hold a total of three webinars from the 11-15 July 2014 so as to better acquaint those wishing to apply for the IMI 2–Call 1 for proposals with the application process and the subject matters of the recently announce initial calls . This information was published in the IMI newsletter on the 30 June.
EAMBES have responded to the mHealth consultation which was launched by the European Commission on the 10 April 2014 and which could serve to promote the value Biomedical Engineering (BME).
The European Research Council (ERC) Work Programme for 2015 has been published on 23 July 2014. The ERC which is funded under Horizon 2020 has the unique idea of not having any particular topics as set criteria for funding and instead relies solely on the “excellence in science” principle to provide long-term funding for high-risk/ground breaking scientific pursuits.
On the 15 July 2014 Mr. Jean-Claude Juncker was elected as the President of the European Commission (EC) for the next legislative term. Mr. Juncker was elected following a 47-minute speech before a secret ballot, with 422 votes in favour (376 needed), 250 votes against, 47 abstentions and 10 void ballots.
On the 30 June 2014, the new Italian Presidency published a document setting out the Council’s work programme as established by the future trio of Presidencies (Italy, Latvia and Luxembourg), covering the period July 2014 to December 2015.
Following the publication on 21 March 2014 of the Regulation 282/2014 of the European Parliament and of the Council on the “Establishment of a third Programme for the Union's action in the field of health (2014-2020) “, on 11 April 2014 the European Commission, Directorate General for Health and Consumers (DG SANCO) hosted an the Information Day on the 3rd European Health Programme.
On the 20 June 2014, the European Council’s Employment and Social Policy Council (EPSCO) discussed the status of the Medical Devices Regulation.
EU-funded project SOCIENTIZE promoting role played by mHealth in the delivery of personalised medicine
The EU-funded project SOCIENTIZE (Society as e-Infrastructure through technology, innovation and creativity) is serving to highlight the role played by mHealth in the effective delivery of personalised patient treatment.
The European Alliance for Personalized Medicine (EAPM) conference “Integrating Personalized medicine into EU Strategy”
The European Alliance for Personalized Medicine (EAPM) will host its second annual conference from the 9-10 September 2014 in Brussels Belgium. The ultimate goal of this conference is to raise awareness among policymakers about the intrinsic role of personalized medicine towards improving the lives of modern day patients.
The current EAMBES President, Birgit Glasmacher, reports the activities the Alliance has been taking care of during the last year and a half.
Commissioner for the Digital Agenda highlights central role of mobile devices in the connected world development agenda
On 21 May 2014 during the United Nations General Assembly (UNGA) in New York City, the Commissioner for the Digital Agenda delivered a noteworthy speech on the subject matter of “Creating a Connected World” during which she spoke about the need for putting ICT at the centre of the Development Agenda.
The Executive Office of the US President on 01 May 2014, published a position entitled “Big Data: seizing opportunities, preserving values”.
Importance of m-Health emphasised during the 8th Celebration of the European Patients’ Rights Day 2014
The 8th celebration of The European Patients’ Rights Day 2014 was held from May 12-14th 2014 in Brussels. The event was entitled “The role of citizens’ organisations in the empowerment of patients with chronic diseases” and was organised by Active Citizenship Network (ACN) with the support of the Public Health Programme European Economic and Social Committee.
EAMBES is organizing an election round to appoint the new President elect and few vacant seats in the Council. Detailed information will be circulate shortly to all the EAMBES membership, in the meantime we encourage you all to nominate a candidate within your organisation.